On the other hand, given the positive association between the presence of lymphoid markers (CD3, CD4, and CD8) and HLA tumor expression, only the low inflammatory subset seems to have the ability to develop an effective T cell infiltrate whenever HLA antigen expression on tumor cells is retained. The gene discussed is CD8A; the disease is neoplasm.